Literature DB >> 22578934

Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?

Charlotte A Gaydos1, Carol Farshy, Mathilda Barnes, Nicole Quinn, Patricia Agreda, Charles A Rivers, Jane Schwebke, John Papp.   

Abstract

Dry-shipped and mailed vaginal swabs collected at home have been used in research studies for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV) by nucleic acid amplification tests (NAATs) in screening programs. A verification study was performed to compare the limit of detection of CT, GC, and TV on swabs that were dry-shipped to paired swabs that were wet-shipped in transport media through the US mail. The Centers for Disease Control and Prevention prepared inocula in sterile water to mock simulated urogenital swabs with high to low concentrations of CT and GC. Replicate swabs were inoculated with 100 μL of dilutions and were dry transported or placed into commercial transport media ("wet") for mailing for NAAT testing. The University of Alabama prepared replicate concentrations of TV, which were similarly shipped and tested by NAAT. All paired dry and wet swabs were detectable for CT. For GC, all paired dry and wet swabs were detectable for GC at concentrations ≥ 10(3). At 10(2) and 10 CFU/mL, the 10 replicate GC results were variably positive. For TV, wet and dry shipped concentrations >10(2) TV/mL tested positive, while results at 10 TV/mL were negative for dry swabs. Holding replicate dry swabs at 55 (○)C 5 days before testing did not affect results. NAATs were able to detect CT, GC, and TV on dry transported swabs. Using NAATs for testing home-collected, urogenital swabs mailed in a dry state to a laboratory may be useful for outreach screening programs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22578934      PMCID: PMC3425852          DOI: 10.1016/j.diagmicrobio.2012.02.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  28 in total

1.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 2.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR.

Authors:  Charlotte A Gaydos; Kimberly A Crotchfelt; Nina Shah; Marie Tennant; Thomas C Quinn; Joel C Gaydos; Kelly T McKee; Anne M Rompalo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 4.  Priorities among effective clinical preventive services: results of a systematic review and analysis.

Authors:  Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg
Journal:  Am J Prev Med       Date:  2006-07       Impact factor: 5.043

5.  Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

Authors:  Barbara Van Der Pol; James A Williams; Donald P Orr; Byron E Batteiger; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2005-11-08       Impact factor: 5.226

6.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

7.  Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

8.  Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

9.  Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis.

Authors:  Ingrid V F van den Broek; Christian J P A Hoebe; Jan E A M van Bergen; Elfi E H G Brouwers; Eva M de Feijter; Johannes S A Fennema; Hannelore M Götz; Rik H Koekenbier; Sander M van Ravesteijn; Eline L M Op de Coul
Journal:  BMC Infect Dis       Date:  2010-04-07       Impact factor: 3.090

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more
  8 in total

1.  Stability Studies on Dry Swabs and Wet Mailed Swabs for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima Assays.

Authors:  Jeanne Moncada; Carey B Clark; Jeffrey Holden; Edward W Hook; Charlotte A Gaydos; Julius Schachter
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

2.  Comparison of the Cepheid GeneXpert CT/NG assay to the Hologic Aptima Combo2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in self-collected rectal swabs.

Authors:  Laura Dize; Barbara Silver; Charlotte Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 2.803

3.  Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.

Authors:  L Dize; S K West; H Mkocha; T C Quinn; C A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-27       Impact factor: 2.803

4.  Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays.

Authors:  Laura Dize; Perry Barnes; Mathilda Barnes; Yu-Hsiang Hsieh; Vincent Marsiglia; Della Duncan; Justin Hardick; Charlotte A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-25       Impact factor: 2.803

5.  Paper-based molecular diagnostic for Chlamydia trachomatis.

Authors:  Jacqueline C Linnes; Andy Fan; Natalia M Rodriguez; Bertrand Lemieux; Huimin Kong; Catherine M Klapperich
Journal:  RSC Adv       Date:  2014-01-01       Impact factor: 3.361

6.  Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji.

Authors:  Colin K Macleod; Robert Butcher; Umesh Mudaliar; Kinisimere Natutusau; Alexandre L Pavluck; Rebecca Willis; Neal Alexander; David C W Mabey; Luisa Cikamatana; Mike Kama; Eric Rafai; Chrissy H Roberts; Anthony W Solomon
Journal:  PLoS Negl Trop Dis       Date:  2016-07-12

7.  Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes.

Authors:  Robert Butcher; Jo Houghton; Tamsyn Derrick; Athumani Ramadhani; Beatriz Herrera; Anna R Last; Patrick A Massae; Matthew J Burton; Martin J Holland; Chrissy H Roberts
Journal:  J Microbiol Methods       Date:  2017-05-06       Impact factor: 2.363

8.  Comparing mail-in self-collected specimens sent via United States Postal Service versus clinic-collected specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in extra-genital sites.

Authors:  Katheryn R Salow; Adam C Cohen; Claire C Bristow; Mark R McGrath; Jeffrey D Klausner
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.